 It's a very exciting time to be in oncology. There is immunotherapy. We harness the body's own immune system to result in cancer killing. This is something that's often well tolerated. We're able to help patients without all the side effects that we are used to hearing about with standard chemotherapy. We often see very durable responses. You know, there are patients who, when they respond, they respond for a very long time. There is a patient that I met a young lady. She was in her early forties. And she presented with stage four melanoma. I remember being in the room with her and telling her her diagnosis and her breaking down and crying. When someone presented with stage four melanoma just a few short years ago, we would be speaking about very short survival. But with immunotherapy, we're often seeing very long responses and people surviving for many years. She was then started on immunotherapy. And it has been two years. When I told her that she was cancer-free, there were several tears of joy in that room. From me as well. We remain on this path together as we continue with keeping a close eye on her for any cancer recurrence. And just seeing that success, it's just very gratifying.